Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Frontline Gastroenterology|August 26, 2017
Evolving strategies to reduce colectomy rates in primary sclerosing cholangitis-inflammatory bowel disease: clinical remission of corticosteroid refractory colitis post-liver transplant with vedolizumabSaqib Mumtaz, Jason Goh, Gideon M Hirschfield, et al.
Journal of Clinical Pathology|May 31, 2023
Landscape of cancer biomarker testing in England following genomic services reconfiguration: insights from a nationwide pathologist surveyPhillipe Taniere, Andrew G Nicholson, John R Gosney, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 2, 2019
In situ growth in early lung adenocarcinoma may represent precursor growth or invasive clone outgrowth-a clinically relevant distinctionDavid Allan Moore, Marco Sereno, Madhumita Das, et al.
Ebiomedicine|November 27, 2018
Validation of epigenetic markers to identify colitis associated cancer: Results of module 1 of the ENDCAP-C studyAndrew D Beggs, Samir Mehta, Jonathan J Deeks, et al.
Clinical Lung Cancer|February 6, 2025
A Retrospective Evaluation of PD-L1 Expression and Heterogeneity in Early-Stage Non-Small Cell Lung Cancer (REPLICA)Eleni C Josephides, Daniel Smith, Andrea Bille, et al.
Biomaterials Science|January 29, 2024
Color changing bioadhesive barrier for peripherally inserted central cathetersIvan Djordjevic, Elizabeth Ellis, Juhi Singh, et al.
The Journal of Molecular Diagnostics : JMD|April 29, 2018
Detection of EGFR Variants in Plasma: A Multilaboratory Comparison of a Real-Time PCR EGFR Mutation Test in EuropeCleo Keppens, John F Palma, Partha M Das, et al.
Molecular Genetics & Genomic Medicine|May 27, 2017
SDHA related tumorigenesis: a new case series and literature review for variant interpretation and pathogenicityRuth T Casey, David B Ascher, Eleanor Rattenberry, et al.
The Lancet Regional Health. Europe|March 13, 2024
Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countriesVincent D de Jager, Wim Timens, Arnaud Bayle, et al.
British Journal of Cancer|September 7, 2021
Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary PathologistsColin R Lindsay, Emily C Shaw, David A Moore, et al.
Pageof 5